Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Galimberti

Showing results (81-90 of 313) with videos related to

Pageof 32
Sort By:
Leukemia Research|April 28, 2004
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patientsSara Galimberti, Francesca Guerrini, Giuseppe Alberto Palumbo, et al.
Frontiers in Oncology|March 6, 2024
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapyRaffaele Palmieri, Atto Billio, Felicetto Ferrara, et al.
Leukemia Research|July 29, 2008
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literatureDaniele Focosi, Fabrizio Maggi, Donatella Pistolesi, et al.
Oncotarget|December 1, 2016
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncologyIacopo Petrini, Serena Barachini, Vittoria Carnicelli, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 28, 2015
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression StudyHakan Savlı, Sara Galimberti, Deniz Sünnetçi, et al.
Transplant Immunology|January 18, 2006
Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity settingSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Leukemia Research|March 30, 2007
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemiaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
Clinical and Experimental Medicine|September 8, 2022
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experienceClaudia Baratè, Teresita Caruso, Fabrizio Mavilia, et al.
Transfusion|July 29, 2008
Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiationLuisa Trombi, Delfo D'Alessandro, Simone Pacini, et al.
Pageof 32

Showing results (81-90 of 313) with videos related to

Sort By:
Pageof 32
Leukemia Research|April 28, 2004
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patientsSara Galimberti, Francesca Guerrini, Giuseppe Alberto Palumbo, et al.
Frontiers in Oncology|March 6, 2024
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapyRaffaele Palmieri, Atto Billio, Felicetto Ferrara, et al.
Leukemia Research|July 29, 2008
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literatureDaniele Focosi, Fabrizio Maggi, Donatella Pistolesi, et al.
Oncotarget|December 1, 2016
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncologyIacopo Petrini, Serena Barachini, Vittoria Carnicelli, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 28, 2015
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression StudyHakan Savlı, Sara Galimberti, Deniz Sünnetçi, et al.
Transplant Immunology|January 18, 2006
Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity settingSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Leukemia Research|March 30, 2007
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemiaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
Clinical and Experimental Medicine|September 8, 2022
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experienceClaudia Baratè, Teresita Caruso, Fabrizio Mavilia, et al.
Transfusion|July 29, 2008
Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiationLuisa Trombi, Delfo D'Alessandro, Simone Pacini, et al.
Pageof 32